ARCHIVES

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Approve Research Network On Screening

August 6, 2010

On More Victory For Sol Garb: FDA Approves THC

June 14, 1985

President’s FY 1992 Budget Seeks $1.81 Billion For NCI, 5.6% Increase, But $800M Below Byspass

February 8, 1991

OMB Reprogramming Ban Criticized

September 20, 1985

Cephalon To Plead Guilty, Pay $425M For Off-Label Marketing.

October 3, 2008

Centers Program Debate Turns Into Full Review Of All issues; Massive Survey, Hearings Planned

October 23, 1987